Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Investig Allergol Clin Immunol ; 27(2): 104-110, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-27727140

RESUMEN

BACKGROUND AND OBJECTIVE: Eosinophilic esophagitis (EoE) is an increasingly prevalent chronic inflammatory disease of the esophagus with an immunoallergic etiology. Few studies have been published on EoE in children and adolescents. The objective of this study was to analyze the demographic, clinical, serologic, endoscopic-histologic, and atopic characteristics of pediatric patients with EoE and to identify atopic and digestive comorbidities. METHODS: We conducted a prospective observational study in children and adolescents (<16 years) assessed in a specialized multidisciplinary EoE unit in a tertiary referral hospital in a central region of Spain between 2011 and 2015. RESULTS: Thirty-five patients were included in the study. Twenty-eight (80%) were male. The mean age was 9.6 years, 83% were atopic, and 28% reported a family history of atopy. The most common symptom was dysphagia (51%). Eosinophilia was detected in the blood of 60% of patients. Eosinophil cationic protein and total IgE were elevated in 88% and 77% of patients, respectively. The most frequent endoscopic finding was linear grooves (57%). Skin tests with aeroallergens were positive in 82% of patients (pollen 62% and food 60%). The main atopic comorbidities were asthma (48%) and rhinoconjunctivitis (37%). Digestive diseases were more often associated with gastritis and Helicobacter pylori infection (17%). CONCLUSIONS: Our results are similar to those previously reported. EoE is more common in boys and in individuals with a history of atopy and sensitization to airborne allergens and food. These results support the consideration of EoE as an atopic disease and underline the important role of allergists in early diagnosis and treatment.


Asunto(s)
Esofagitis Eosinofílica/diagnóstico , Esofagitis Eosinofílica/epidemiología , Esofagoscopía , Hipersensibilidad Inmediata/diagnóstico , Hipersensibilidad Inmediata/epidemiología , Adolescente , Distribución por Edad , Biomarcadores/sangre , Niño , Preescolar , Diagnóstico Precoz , Esofagitis Eosinofílica/sangre , Esofagitis Eosinofílica/inmunología , Femenino , Hipersensibilidad a los Alimentos/diagnóstico , Hipersensibilidad a los Alimentos/epidemiología , Hipersensibilidad a los Alimentos/inmunología , Humanos , Hipersensibilidad Inmediata/sangre , Hipersensibilidad Inmediata/inmunología , Masculino , Valor Predictivo de las Pruebas , Prevalencia , Pronóstico , Estudios Prospectivos , Factores de Riesgo , Pruebas Serológicas , Distribución por Sexo , Pruebas Cutáneas , España/epidemiología , Centros de Atención Terciaria
3.
Allergol Immunopathol (Madr) ; 42(5): 407-14, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-23845923

RESUMEN

BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic inflammatory emerging disease of the oesophagus with immunoallergic aetiology. The allergens involved have not been clearly defined and may depend on the exposure of the population to aeroallergens or food antigens. MATERIALS AND METHODS: Patients diagnosed with EoE between 2006 and 2011 were referred to our Allergy Section. Patch and skin prick tests (SPT) with aeroallergens and foods were performed, and total and specific IgE levels, eosinophil cationic protein levels and eosinophil count were determined. RESULTS: 43 patients were included. 36 (83.7%) were atopic. 29 patients presented choking, 19 dysphagia, 9 food impaction with urgent endoscopy, 4 chest pain, 1 isolated vomiting and 1 epigastric pain. 22 had two or more symptoms. The mean duration of symptoms was 3.73 years. Concomitant allergic diseases included rhinoconjunctivitis and/or asthma (31 patients), IgE food allergy (21 patients) and atopic dermatitis (3 patients). 32 (74%) were sensitized to aeroallergens, of which 90% were sensitized to pollens; 23 (54%) showed positive tests to foods and 12 of them (52%) to lipid transfer proteins (LTP). Of the 29 pollen-allergic patients, 15 (52%) were sensitized to plant foods and 10 (34.4%) to LTP. CONCLUSIONS: Our findings support those reported in the literature: the disease is more common in men aged 30-40 years with at least a three-year history of symptoms of esophageal dysfunction, sensitized to pollens, the predominant aeroallergen in our area, but also to plant foods or panallergens. These results increase the evidence for an immunoallergic aetiology and can help us in the early diagnosis of EoE.


Asunto(s)
Esofagitis Eosinofílica/inmunología , Hipersensibilidad Inmediata/inmunología , Adolescente , Adulto , Niño , Estudios Transversales , Esofagitis Eosinofílica/complicaciones , Femenino , Hipersensibilidad a los Alimentos/complicaciones , Hipersensibilidad a los Alimentos/epidemiología , Hipersensibilidad a los Alimentos/inmunología , Humanos , Hipersensibilidad Inmediata/complicaciones , Hipersensibilidad Inmediata/epidemiología , Masculino , Persona de Mediana Edad , Rinitis Alérgica Estacional/complicaciones , Rinitis Alérgica Estacional/epidemiología , Rinitis Alérgica Estacional/inmunología , Pruebas Cutáneas , España/epidemiología , Adulto Joven
7.
Aliment Pharmacol Ther ; 43(4): 534-40, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26662868

RESUMEN

BACKGROUND: Proton pump inhibitor-responsive oesophageal eosinophilia (PPI-REE) is common in patients with suspected eosinophilic oesophagitis (EoE). However, the long-term efficacy of PPIs and the best maintenance doses are yet to be defined. AIM: To evaluate the durability of the response to PPI therapy after tapering PPI doses in PPI-REE patients. METHODS: Prospective study conducted on PPI-REE patients. Upon complete remission on high-dose PPI therapy (omeprazole 40 mg b.d. for 8 weeks), PPI doses were tapered followed by an endoscopic procedure after each dose reduction. The primary outcomes were sustained clinical and histological remission (<15 eos/HPF) after decreasing PPI doses. RESULTS: From a total of 121 patients with suspected EoE, 40 (33%) achieved complete remission on high-dose PPIs and were given a diagnosis of PPI-REE. No patient in histological remission showed symptom relapse, but half of patients with relapsing oesophageal inflammation were in clinical remission. After reduction to omeprazole 40 mg once daily, 38/31 (81%) remained in complete remission. Among these latter patients, 15/18 (83%) were kept in remission with omeprazole 20 mg once daily. As for side effects, only asymptomatic hypertransaminasemia and oesophageal candidiasis were observed in two patients while receiving high doses of omeprazole. CONCLUSIONS: Most PPI-responsive oesophageal eosinophilia patients show sustained clinical and histological remission with daily PPI doses equal to or below 40 mg of omeprazole. As adverse effects only appeared with the highest dose of omeprazole, it would be advisable to individualise the dose of PPIs for each patient, lowering it to the minimum capable of maintaining the disease controlled.


Asunto(s)
Esofagitis Eosinofílica/tratamiento farmacológico , Omeprazol/uso terapéutico , Inhibidores de la Bomba de Protones/uso terapéutico , Adolescente , Adulto , Anciano , Relación Dosis-Respuesta a Droga , Endoscopía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Omeprazol/administración & dosificación , Estudios Prospectivos , Inhibidores de la Bomba de Protones/administración & dosificación , Recurrencia , Inducción de Remisión , Adulto Joven
8.
J. investig. allergol. clin. immunol ; 27(2): 96-110, 2017. tab
Artículo en Inglés | IBECS (España) | ID: ibc-162318

RESUMEN

Background and objective: Eosinophilic esophagitis (EoE) is an increasingly prevalent chronic inflammatory disease of the esophagus with an immunoallergic etiology. Few studies have been published on EoE in children and adolescents. The objective of this study was to analyze the demographic, clinical, serologic, endoscopic-histologic, and atopic characteristics of pediatric patients with EoE and to identify atopic and digestive comorbidities. Methods: We conducted a prospective observational study in children and adolescents (<16 years) assessed in a specialized multidisciplinary EoE unit in a tertiary referral hospital in a central region of Spain between 2011 and 2015. Results: Thirty-five patients were included in the study. Twenty-eight (80%) were male. The mean age was 9.6 years, 83% were atopic, and 28% reported a family history of atopy. The most common symptom was dysphagia (51%). Eosinophilia was detected in the blood of 60% of patients. Eosinophil cationic protein and total IgE were elevated in 88% and 77% of patients, respectively. The most frequent endoscopic finding was linear grooves (57%). Skin tests with aeroallergens were positive in 82% of patients (pollen 62% and food 60%). The main atopic comorbidities were asthma (48%) and rhinoconjunctivitis (37%). Digestive diseases were more often associated with gastritis and Helicobacter pylori infection (17%). Conclusions: Our results are similar to those previously reported. EoE is more common in boys and in individuals with a history of atopy and sensitization to airborne allergens and food. These results support the consideration of EoE as an atopic disease and underline the important role of allergists in early diagnosis and treatment (AU)


Introducción y objetivos: La esofagitis eosinofílica (EoE) es una enfermedad inflamatoria crónica, emergente del esófago, con etiología inmunoalérgica. Hasta ahora, pocos estudios sobre esta enfermedad en niños y adolescentes han sido publicados. El objetivo de este estudio era estudiar las características epidemiológicas, clínicas, serológicas y endoscópico-histológicas de estos pacientes y las comorbilidades alergológicas y digestivas. Metodología: Es un estudio observacional descriptivo en niños y adolescentes (<16 años), estudiados en una unidad multidisciplinar en un hospital de tercer nivel en una región del centro de España. Resultados: Se incluyeron en el estudio 35 pacientes. 28 eran hombres (80%). La edad media era 9,6 años, el 83% eran atópicos y tenían antecedentes familiares de atopia el 28%. El síntoma más común fue la disfagia (51%). Se detectó eosinofilia en sangre en el 60% de los pacientes. La proteína catiónica del eosinófilo y la Ig E total estaban elevadas en el 78% y 77% de los pacientes, respectivamente. El hallazgo endoscópico más frecuente fueron los surcos lineales (62%). Loa tests cutáneos fueron positivos en el 82% de los pacientes (polen 62%, alimentos 60%). Las comorbilidades atópicas fueron, asma (48%) y rinoconjuntivitis (37%). Las enfermedades digestivas más asociadas fueron gastritis e infección por Helicobacter pylori (17%). Conclusiones: Nuestros resultados son similares a los publicados previamente. La EoE es mas frecuente en niños, con historia de atopia, sensibilizados a aeroalérgenos o alimentos. Estos resultados apoyan que la EoE pueda considerarse una enfermedad atópica y el importante papel del alergólogo en el diagnóstico y tratamiento precoz de esta enfermedad (AU)


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Esofagitis Eosinofílica/epidemiología , Esofagitis Eosinofílica/etiología , Esofagitis Eosinofílica/inmunología , Esofagoscopía , Diagnóstico Precoz , Comorbilidad/tendencias , Alérgenos/inmunología , Alérgenos/efectos de la radiación , Gastritis/complicaciones , Gastritis/inmunología , Helicobacter pylori/inmunología , Helicobacter pylori/aislamiento & purificación
11.
Allergol. immunopatol ; 42(5): 407-414, sept.-oct. 2014. tab
Artículo en Inglés | IBECS (España) | ID: ibc-127273

RESUMEN

BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic inflammatory emerging disease of the oesophagus with immunoallergic aetiology. The allergens involved have not been clearly defined and may depend on the exposure of the population to aeroallergens or food antigens. MATERIALS AND METHODS: Patients diagnosed with EoE between 2006 and 2011 were referred to our Allergy Section. Patch and skin prick tests (SPT) with aeroallergens and foods were performed, and total and specific IgE levels, eosinophil cationic protein levels and eosinophil count were determined. RESULTS: 43 patients were included. 36 (83.7%) were atopic. 29 patients presented choking, 19 dysphagia, 9 food impaction with urgent endoscopy, 4 chest pain, 1 isolated vomiting and 1 epigastric pain. 22 had two or more symptoms. The mean duration of symptoms was 3.73 years. Concomitant allergic diseases included rhinoconjunctivitis and/or asthma (31 patients), IgE food allergy (21 patients) and atopic dermatitis (3 patients).32 (74%) were sensitized to aeroallergens, of which 90% were sensitized to pollens; 23 (54%) showed positive tests to foods and 12 of them (52%) to lipid transfer proteins (LTP).Of the 29 pollen-allergic patients, 15 (52%) were sensitized to plant foods and 10 (34.4%) to LTP. CONCLUSIONS: Our findings support those reported in the literature: the disease is more common in men aged 30-40 years with at least a three-year history of symptoms of esophageal dysfunction, sensitized to pollens, the predominant aeroallergen in our area, but also to plant foods or panallergens. These results increase the evidence for an immunoallergic aetiology and can help us in the early diagnosis of EoE


No disponible


Asunto(s)
Humanos , Masculino , Femenino , Esófago/citología , Esófago/inmunología , Hipersensibilidad/inmunología , Esofagitis/sangre , Esofagitis/inmunología , Esofagitis/terapia , Alérgenos/análisis , Alérgenos/inmunología , Gastroenterología/tendencias , Polen/inmunología , Estudios Prospectivos , Antígenos T-Independientes/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA